Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Feb 14:8:569.
doi: 10.1038/msb.2012.2.

miRNAs versus oncogenes: the power of social networking

Marcos Malumbres  1
Affiliations
Comment

miRNAs versus oncogenes: the power of social networking

Marcos Malumbres. Mol Syst Biol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author declares that he has no conflict of interest.

Figures

Figure 1
Figure 1
Control of the EGFR pathway and cell cycle entry by miRNAs. The EGF receptor uses several downstream pathways to drive cell cycle progression. Similarly, miRNAs simultaneously modulate several of these downstream pathways to effect cell cycle progression. For instance, miR-124 co-downregulates AKT2, p38MAPK and STAT3 to inhibit the EGFR pathway leading to CDK downregulation, p27Kip1 upregulation and cell cycle inhibition. miR-147 also participates in AKT2 downregulation and simultaneously represses Cyclins (Cyc). These two examples show how a single miRNA can target several components of a signaling pathway and how two miRNAs can co-regulate the same target. These data also suggest the therapeutic value of miR-124 and miR-147 in treating EGFR-dependent tumors. Only a few representative molecules are shown for clarity.
See this image and copyright information in PMC

Comment on

References

    1. Avraham R, Sas-Chen A, Manor O, Steinfeld I, Shalgi R, Tarcic G, Bossel N, Zeisel A, Amit I, Zwang Y, Enerly E, Russnes HG, Biagioni F, Mottolese M, Strano S, Blandino G, Borresen-Dale AL, Pilpel Y, Yakhini Z, Segal E et al. (2010) EGF decreases the abundance of microRNAs that restrain oncogenic transcription factors. Sci Signal 3: ra43. - PubMed
    1. Bueno MJ, Gomez de Cedron M, Gomez-Lopez G, Perez de Castro I, Di Lisio L, Montes-Moreno S, Martinez N, Guerrero M, Sanchez-Martinez R, Santos J, Pisano DG, Piris MA, Fernandez-Piqueras J, Malumbres M (2011) Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway. Blood 117: 6255–6266 - PubMed
    1. Bueno MJ, Malumbres M (2011) MicroRNAs and the cell cycle. Biochim Biophys Acta 1812: 592–601 - PubMed
    1. Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y, Cai X, Wang K, Wang G, Ba Y, Zhu L, Wang J, Yang R, Zhang Y, Ren Z, Zen K, Zhang J, Zhang CY (2009) Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 28: 1385–1392 - PubMed
    1. Garofalo M, Romano G, Di Leva G, Nuovo G, Jeon YJ, Ngankeu A, Sun J, Lovat F, Alder H, Condorelli G, Engelman JA, Ono M, Rho JK, Cascione L, Volinia S, Nephew KP, Croce CM (2011) EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nat Med 18: 74–82 - PMC - PubMed